Breaking News Instant updates and real-time market news.

INTC

Intel

$49.40

1.45 (3.02%)

10:12
01/24/19
01/24
10:12
01/24/19
10:12

Technical Take: Intel moves sharply higher ahead of earnings news

The stock was last up over 2.9% to $49.35 in a very active semiconductor sector. At current price the big level to watch is at the $50 area. A move above $50 would clear a range high area going back to August of last year. Range breaks tend to continue moving in the direction of the break for some time, dependent on the length of time the range has been developing. The $50.60 area would be the next level to watch above $50. Support is at $48.70, the opening price of the day.

  • 24

    Jan

  • 25

    Feb

  • 25

    Mar

INTC Intel
$49.40

1.45 (3.02%)

01/17/19
SBSH
01/17/19
NO CHANGE
SBSH
On Semiconductor stocks, Citi says 'time to step in'
Citi analyst Christopher Danely says it is "time to step in" to shares of Semiconductors. Although he expects another cut to consensus estimates, he believes it will be smaller than the cut following the October quarter. This should be good for Semiconductor stocks and would indicate a bottom is forming with the worst cuts behind us, Danely tells investors in a research note previewing the sector's Q4 earnings. Less bad earnings reductions will be viewed positively given the "poor sentiment and the second derivative is improving," says the analyst. As such, Danely expects the stocks to rally during this earnings season. Names in the Semi space include AMD (AMD), Intel (INTC), Marvell (MRVL), Microchip (MCHP), Micron (MU), Nvidia (NVDA), Qualcomm (QCOM) and Texas Instruments (TXN).
01/17/19
JPMS
01/17/19
NO CHANGE
JPMS
JPMorgan sees bottom forming in Semi stocks ahead of second half rally
JPMorgan analyst Harlan Sur expects most of the Semiconductor companies he covers to report December quarter numbers in-line with his and consensus expectations. The stocks should start to discount improving fundamentals in the first half of 2019 and should be accumulated on any further pullbacks, Sur tells investors in a research note. While the analyst anticipates another round of consensus estimate cuts in the January earnings season, he believes further share downside is limited since many of his stocks are down 25% from the peak in March/June of last year. In large cap stocks, Sur's top pick is Broadcom (AVGO) and he also favors Nvidia (NVDA), Intel (INTC), Maxim Integrated (MXIM) and Micron Technology (MU). The analyst's small cap top picks include Inphi (IPHI) and Mellanox (MLNX). In Semi Capital Equipment, Sur favors Lam Research (LRCX).
01/18/19
BARD
01/18/19
NO CHANGE
Target $20
BARD
Neutral
Baird reduces AMD estimates, citing EPYC challenges
Baird analyst Tristan Gerra reduced his estimates on AMD (AMD) as he believes the company's 10% market share target for its EPYC server processors appears challenged. The analyst expects Intel's (INTC) Xeon Scalable market share to stabilize in the second half of the year as the performance specs on next-gen Xeon platform appear to be ahead of AMD in segments where both companies compete. Additionally, he has heard that Intel is likely to take a more aggressive stance on pricing this year, after a significant price hike last year, the analyst noted. Gerra maintained his Neutral rating and lowered his price target to $20 from $23 on AMD shares.
01/22/19
UBSW
01/22/19
NO CHANGE
Target $60
UBSW
Buy
Intel Q4 results should be ok, but 10nm strategy the key, says UBS
UBS analyst Timothy Arcuri believes Intel's (INTC) Q4 results will be ok, but sees a downside bias for March guidance due to the data center group. He expects an overall constructive call but said manufacturing strategy and 10nm progress remains the most important narrative and he expects that to get more discussion. He also said the new CEO will need to decide the strategic importance of both the non-volatile memory solutions group and the Apple (AAPL) modem business. Arcuri reiterated his Buy rating and $60 price target on Intel shares.

TODAY'S FREE FLY STORIES

PXD

Pioneer Natural

$138.59

2.9 (2.14%)

, XOM

Exxon Mobil

$81.08

0.92 (1.15%)

05:50
03/19/19
03/19
05:50
03/19/19
05:50
Downgrade
Pioneer Natural, Exxon Mobil, Chevron rating change  »

Pioneer Natural…

PXD

Pioneer Natural

$138.59

2.9 (2.14%)

XOM

Exxon Mobil

$81.08

0.92 (1.15%)

CVX

Chevron

$125.88

0.57 (0.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Apr

  • 22

    May

BKNG

Booking Holdings

$1,756.46

4.72 (0.27%)

05:49
03/19/19
03/19
05:49
03/19/19
05:49
Downgrade
Booking Holdings rating change  »

Booking Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WP

Worldpay

05:48
03/19/19
03/19
05:48
03/19/19
05:48
Downgrade
Worldpay rating change  »

Worldpay downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Apr

O

Realty Income

$71.02

-0.22 (-0.31%)

05:48
03/19/19
03/19
05:48
03/19/19
05:48
Downgrade
Realty Income rating change  »

Realty Income downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLGT

Teligent

$1.29

-0.11 (-7.86%)

05:47
03/19/19
03/19
05:47
03/19/19
05:47
Downgrade
Teligent rating change  »

Teligent downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENPH

Enphase Energy

$9.67

0.61 (6.73%)

05:47
03/19/19
03/19
05:47
03/19/19
05:47
Downgrade
Enphase Energy rating change  »

Enphase Energy downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

ZUO

Zuora

$23.08

-0.33 (-1.41%)

05:47
03/19/19
03/19
05:47
03/19/19
05:47
Upgrade
Zuora rating change  »

Zuora upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

  • 23

    Apr

ARGO

Argo Group

$68.09

-0.2 (-0.29%)

05:46
03/19/19
03/19
05:46
03/19/19
05:46
Upgrade
Argo Group rating change  »

Argo Group upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TUSK

Mammoth Energy

$18.24

0.31 (1.73%)

05:46
03/19/19
03/19
05:46
03/19/19
05:46
Downgrade
Mammoth Energy rating change  »

Mammoth Energy downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

UROV

Urovant Sciences

$14.06

0.07 (0.50%)

05:40
03/19/19
03/19
05:40
03/19/19
05:40
Conference/Events
Urovant Sciences to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

NFLX

Netflix

$363.27

1.64 (0.45%)

, AAPL

Apple

$188.03

1.83 (0.98%)

05:40
03/19/19
03/19
05:40
03/19/19
05:40
Periodicals
Netflix not a tech company, and won't be on Apple video, CEO tells Recode »

Netflix (NFLX) CEO Reed…

NFLX

Netflix

$363.27

1.64 (0.45%)

AAPL

Apple

$188.03

1.83 (0.98%)

DIS

Disney

$113.07

-1.89 (-1.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Apr

RHHBY

Roche

$0.00

(0.00%)

05:16
03/19/19
03/19
05:16
03/19/19
05:16
Hot Stocks
Roche announces FDA approval of Tecentriq with chemotherapy for lung cancer »

Roche announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Apr

  • 17

    Apr

  • 19

    Aug

  • 04

    Nov

05:10
03/19/19
03/19
05:10
03/19/19
05:10
General news
FX Action: USD-CAD has remained steady-but-heavy »

FX Action: USD-CAD has…

ALGN

Align Technology

$253.83

1.51 (0.60%)

05:09
03/19/19
03/19
05:09
03/19/19
05:09
Recommendations
Align Technology analyst commentary  »

Align Technology price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGMB

MGM Holdings

$0.00

(0.00%)

, MGM.B

MGM Holdings

$0.00

(0.00%)

05:03
03/19/19
03/19
05:03
03/19/19
05:03
Recommendations
MGM Holdings, MGM Holdings analyst commentary at Imperial Capital »

MGM Holdings price target…

MGMB

MGM Holdings

$0.00

(0.00%)

MGM.B

MGM Holdings

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CWH

Camping World

$13.45

-0.07 (-0.52%)

04:55
03/19/19
03/19
04:55
03/19/19
04:55
Downgrade
Camping World rating change  »

Camping World downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

04:55
03/19/19
03/19
04:55
03/19/19
04:55
General news
Breaking General news story  »

8-Week Bill Announcement…

NOAH

Noah Holdings

$46.87

0.5 (1.08%)

04:55
03/19/19
03/19
04:55
03/19/19
04:55
Conference/Events
Noah Holdings management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 20

    Mar

  • 21

    Mar

  • 22

    Mar

04:55
03/19/19
03/19
04:55
03/19/19
04:55
Conference/Events
UBS technology analyst to hold an analyst/industry conference call »

Technology Analyst Lowe…

AHT

Ashford Hospitality

$4.81

0.09 (1.91%)

04:55
03/19/19
03/19
04:55
03/19/19
04:55
Conference/Events
Ashford Hospitality management to meet with B. Riley FBR »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

ALDR

Alder Biopharmaceuticals

$13.72

0.21 (1.55%)

04:55
03/19/19
03/19
04:55
03/19/19
04:55
Conference/Events
Alder Biopharmaceuticals management to meet with SVB Leerink »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

JMP

JMP Group

$3.86

-0.085 (-2.15%)

04:55
03/19/19
03/19
04:55
03/19/19
04:55
Conference/Events
JMP Group management to meet with Barrington »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

ANDE

Andersons

$34.32

-0.26 (-0.75%)

04:55
03/19/19
03/19
04:55
03/19/19
04:55
Conference/Events
Andersons management to meet with Buckingham »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 07

    May

MKTX

MarketAxess

$237.77

4.27 (1.83%)

04:55
03/19/19
03/19
04:55
03/19/19
04:55
Conference/Events
MarketAxess management to meet with Buckingham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

MGA

Magna

$49.29

0.45 (0.92%)

04:55
03/19/19
03/19
04:55
03/19/19
04:55
Conference/Events
Magna management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 21

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.